Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fitbit-Style tracking could boost chronic pain rehab

NCT ID NCT05009459

Symptom relief Sponsor: Dalarna University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests whether a tool called eVIS can help people with chronic pain become more physically active during their rehabilitation. Participants in the eVIS group wear a Fitbit and use a web app to see their daily steps and pain levels, alongside their usual rehab program. The study compares them to people receiving standard rehab alone, measuring changes in physical health and activity over six months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
eVIS, a behavioral intervention combining a wrist-worn Fitbit activity tracker with a web app that visualizes daily steps and pain reports to support physical activity goals
What this could lead to
If it works, eVIS could help people with chronic pain stay more active and feel better during rehabilitation, offering a simple tool to improve rehab outcomes.
What could go wrong
This is an early trial, and the intervention may not improve outcomes for everyone. Some participants might find the tracking burdensome or not see meaningful changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 280 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2021

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 67 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Swedish IPRP treatment criterias will be applied as patients entering the trial must be accepted for IPRP: Principal IPRP inclusion criteria are: * persistent or intermittent pain lasting ≥3 months * pain affecting daily activities to a large extent, * completed systematic assessment and non-pharmacological optimization is completed, * screening for psychosocial risk factors and differential diagnosis completed In addition the following criterias will be appled: * Patients aged 18-67 years. * Patients must be able to hear, see, and comprehend spoken and written Swedish * Daily access to a computer, smartphone, or tablet. Exclusion Criteria: * Patients who need to use a walking aid indoors. * Patients living with pain caused by systemic disease or malignancies.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dalarna University

    RECRUITING

    Falun, SE-791 88, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.